데이터가 없습니다.

1. Difference in prognostic impact of lateral pelvic lymph node metastasis between pre- and post-neoadjuvant chemoradiotherapy in rectal cancer patients [ ANNALS OF SURGICAL TREATMENT AND RESEARCH ] - 2023.04.01
2. Can clinicopathologic high-risk features in T3N0 colon cancer be reliable prognostic factors? [ ANNALS OF SURGICAL TREATMENT AND RESEARCH ] - 2023.02.01
3. Lifestyle interventions after colorectal cancer surgery using a mobile digital device: A study protocol for a randomized controlled trial [ MEDICINE ] - 2022.10.14
4. The Prognostic Reliability of Lymphovascular Invasion for Patients with T3N0 Colorectal Cancer in Adjuvant Chemotherapy Decision Making [ Cancers ] - 2022.06.08
5. Cardiovascular morbidities in postoperative colorectal cancer patients [ SCIENTIFIC REPORTS ] - 2021.11.01
6. Optimal postoperative surveillance strategies for stage III colorectal cancer [ WORLD JOURNAL OF GASTROINTESTINAL SURGERY ] - 2021.09.27
7. Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates [ CANCERS ] - 2021.09.27
8. Evaluating the benefit of adjuvant chemotherapy in patients with ypT0-1 rectal cancer treated with preoperative chemoradiotherapy [ WORLD JOURNAL OF GASTROINTESTINAL SURGERY ] - 2021.09.27
9. Optimal Postoperative Surveillance Strategies for Colorectal Cancer: A Retrospective Observational Study [ CANCERS ] - 2021.07.13
10. Improvement in the Assessment of Response to Preoperative Chemoradiotherapy for Rectal Cancer Using Magnetic Resonance Imaging and a Multigene Biomarker [ CANCERS ] - 2021.07.12
11. Influence of Postoperative Changes in Sarcopenia on Long-Term Survival in Non-Metastatic Colorectal Cancer Patients [ CANCERS ] - 2021.05.17
12. Impact of the COVID-19 Pandemic on Surgical Treatment Patterns for Colorectal Cancer in a Tertiary Medical Facility in Korea [ CANCERS ] - 2021.05.06
13. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma [ MODERN PATHOLOGY ] - 2021.01.01
14. Lateral lymph node and its association with distant recurrence in rectal cancer: A clue of systemic disease [ SURGICAL ONCOLOGY-OXFORD ] - 2020.12.01
15. Effects of PrObiotics on the Symptoms and Surgical ouTComes after Anterior REsection of Colon Cancer (POSTCARE): A Randomized, Double-Blind, Placebo-Controlled Trial [ Journal of clinical medicine ] - 2020.07.10
16. Association of Body Composition with Long-Term Survival in Non-metastatic Rectal Cancer Patients [ CANCER RESEARCH AND TREATMENT ] - 2020.04.01
17. A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer [ Cancers ] - 2020.03.26
18. Management of isolated para-aortic lymph node recurrence after surgery for colorectal cancer [ ANNALS OF SURGICAL TREATMENT AND RESEARCH ] - 2020.03.01
19. Benefits of repeated resections for liver and lung metastases from colorectal cancer [ Asian Journal of Surgery ] - 2020.01.01
20. A Multigene Model for Predicting Tumor Responsiveness After Preoperative Chemoradiotherapy for Rectal Cancer [ INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ] - 2019.11.15
21. Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning [ ANNALS OF SURGICAL TREATMENT AND RESEARCH ] - 2019.11.01
22. Effect of Responsiveness of Lymph Nodes to Preoperative Chemoradiotherapy in Patients With Rectal Cancer on Prognosis After Radical Resection [ CLINICAL COLORECTAL CANCER ] - 2019.06.01
23. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer [ CLINICAL COLORECTAL CANCER ] - 2019.06.01
24. Does the Different Locations of Colon Cancer Affect the Oncologic Outcome? A Propensity-Score Matched Analysis [ Annals of coloproctology ] - 2019.02.28
25. Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent "no tumor" status? [ ANNALS OF SURGICAL TREATMENT AND RESEARCH ] - 2019.02.01
26. Simple and low-cost sampling of cell-free nucleic acids from blood plasma for rapid and sensitive detection of circulating tumor DNA [ Advanced Science ] - 2018.10.18
27. Outcomes of patients with abdominoperineal resection (APR) and low anterior resection (LAR) who had very low rectal cancer [ MEDICINE ] - 2017.10.01
28. Peri-treatment change of anorectal function in patients with rectal cancer after preoperative chemoradiotherapy [ ONCOTARGET ] - 2017.08.27
29. Prediction of radio-responsiveness with immune-profiling in patients with rectal cancer [ ONCOTARGET ] - 2017.07.25
30. Post-pulmonary metastatsectomy prognosis after curative resection for colorectal cancer [ ONCOTARGET ] - 2017.05.01
31. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer? [ Oncotarget ] - 2017.02.07
32. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer [ MEDICINE ] - 2016.09.01
33. Is Preoperative Chemoradiotherapy Beneficial for Sphincter Preservation in Low-Lying Rectal Cancer Patients? [ MEDICINE ] - 2016.05.01
34. Preoperative chemoradiotherapy for clinically diagnosed T3N0 rectal cancer [ SURGERY TODAY ] - 2016.01.01
35. Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer [ MEDICINE ] - 2015.12.28
36. Is patholoigc near-total regression an appropriate indicator of a good response to preoperative chemoradiotherapy based on oncologic outcome of disease? [ MEDICINE ] - 2015.12.01
37. Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer [ INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS ] - 2015.07.01
38. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy [ WORLD JOURNAL OF GASTROENTEROLOGY ] - 2015.03.21
39. Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer [ WORLD JOURNAL OF GASTROENTEROLOGY ] - 2015.01.14

1. 대장암 생존자 유래 항체 레지스트리 구축을 통한 맞춤형 항암 치료항체 개발 - 2022.02.24 ~ 2024.02.28
2. 전방절제술 전후 프로바이오틱스 섭취의 장기 효과에 관한 후향적 연구 POSTCARE 임상시험의 추적 관찰 - 2021.11.25 ~ 2022.12.31
3. 대장암 환자의 진단, 치료, 예후 예측을 위한 액체생검 기술 적용 플랫폼 및 임상데이터베이스 구축 - 2020.01.01 ~ 2020.12.31
4. 국소 진행성 직장암 환자에서 수술전 항암방사선 요법의 맞춤치료 구현을 위한 방사선 반응성 평가 지표 발굴 - 2019.03.01 ~ 2019.05.31
5. 국소 진행성 직장암 환자에서 수술전 항암방사선 요법의 맞춤치료 구현을 위한 방사선 반응성 평가 지표 발굴 - 2018.05.01 ~ 2019.02.28
6. 직장암 환자에서 방사선 치료반응 예측 혈액 기반 바이오마커 발굴 및 코호트 구축유지 - 2018.01.01 ~ 2018.12.31
7. 다중형광 분석을 이용한 대장암 환자의 면역프로파일링 - 2018.01.01 ~ 2018.12.31
8. 대장암 및 직장암에서 맞춤치료 도입을 위한 액체시료 기반 생체지표 발굴을 위한 시료 확보 및 과정 확립 - 2017.07.03 ~ 2020.03.31
9. 국소 진행성 직장암 환자에서 수술전 항암방사선 요법의 맞춤치료 구현을 위한 방사선 반응성 평가 지표 발굴 - 2017.06.01 ~ 2018.03.31
10. 대장암 및 직장암에서 맞춤치료 도입을 위한 액체시료 기반 생체지표 발굴을 위한 시료 확보 및 과정 확립 - 2017.01.01 ~ 2017.12.31
11. 전방절제 대장암 수술 후 증상 개선에 미치는 메치니코프 프로바이오틱스의 유효성을 평가하기 위한 다기관, 무작위배정, 이중눈가림, 위약대조 임상시험 - 2016.11.07 ~ 2017.10.01
12. 국소 진행성 직장암 환자에서 수술전 항암방사선 요법의 맞춤치료 구현을 위한 방사선 반응성 평가 지표 발굴 - 2016.06.01 ~ 2017.05.31
13. 직장암에서의 수술 전 항암방사선 치료의 반응성 예측 모델 확립을 위한 샘플 확보 및 임상적 인증 - 2016.05.23 ~ 2016.12.31
14. 국소 진행성 직장암 환자에서 수술전 항암방사선 요법의 맞춤치료 구현을 위한 방사선 반응성 평가 지표 발굴 - 2016.01.01 ~ 2016.12.31

데이터가 없습니다.

      데이터가 없습니다.

 공지